Back to News
Market Impact: 0.25

BofA raises American International Group stock price target on strong results

UBSAIGMSGSCRBG
Corporate EarningsAnalyst EstimatesAnalyst InsightsCompany FundamentalsManagement & GovernanceArtificial Intelligence

BofA Securities raised AIG’s price target to $84 from $79 while keeping a Neutral rating, citing stronger-than-expected results. The quarter beat both BofA’s $1.74 EPS forecast and Street consensus of $1.87, helped by $180 million in catastrophe losses versus $238 million expected, $108 million of favorable reserve development, and an 86.6% underlying combined ratio, 125 bps better than forecast. The article also highlights leadership transition and AI-related strategic collaboration, but the main market driver is the modestly improved earnings outlook.

Analysis

The key market message is not the forecast bump itself, but that AIG is transitioning from a “prove it” story to a “multiple can de-rate or re-rate based on execution quality” story. Positive reserve development and benign catastrophe losses improve near-term earnings optics, but the bigger second-order effect is capital flexibility: higher-quality earnings should support buybacks and internal growth funding at a moment when the new CEO inherits a cleaner starting point. The market is likely underappreciating how much of the current debate is about persistence. Cat loss normalization can reverse in one quarter, but reserve development and underwriting discipline typically rerate over 4-8 quarters if they hold up through multiple renewal cycles. The real risk is that investors extrapolate a single strong print into a structurally higher earnings base, only to see the next few quarters give back several cents from weather, pricing pressure, or weaker investment income sensitivity. AIG also sits in a subtle competitive pocket versus peers that are more leveraged to “quality of earnings” narratives. If management sustains underwriting improvement, the stock should trade more like a disciplined commercial P&C compounder than a legacy insurer, which creates room for multiple expansion even without dramatic EPS upgrades. Conversely, if the AI/automation initiatives fail to materially reduce expense ratio or improve quote-to-bind economics, the market will likely treat them as promotional rather than value-accretive. The contrarian angle is that consensus may be too focused on near-term earnings beats and not enough on governance/transition risk. CEO succession can be a catalyst for continuity, but it also resets expectations on capital allocation, expense discipline, and how aggressively management will pursue growth versus ROE. That makes the next 2-3 quarters the critical window: if underwriting stays above trend and buybacks accelerate, the stock can grind higher; if not, the recent optimism becomes vulnerable to a fast multiple compression.